6月7日，世界知名的沃伦•阿尔珀特奖（Warren Alpert Prize）公布了2017年的获奖人名单，肿瘤免疫疗法先驱、福建医科大学杰出校友、美国耶鲁大学陈列平教授获得该奖。该奖项是由沃伦·阿尔伯特基金会与哈佛大学医学院联合授予的，旨在推动人类在生物医学方面的研究。
沃伦·阿尔珀特奖(Warren Alpert Prize)是由已故的慈善家及商业人士Warren Alpert和Warren Alpert基金会于1987年成立的。 沃伦·阿尔珀特奖是一个国际奖项，自成立以来，七位诺贝尔奖的获奖者已获该奖。 该奖项由哈佛医学院和位于罗德岛州普罗维登斯(Providence, Rhode Island)的沃伦·阿尔珀特基金会合作管理。 每年秋季，哈佛医学院年度科学研讨会，以纪念获得者。
Dr. Lieping Chen obtained his medical degree in 1982 from Fujian Medical School, China. After completion of his training in hematology and oncology at Fujian Union Hospital and Beijing Union Medical College, Dr. Chen earned a Ph.D. in experimental pathology from Drexel University College of Medicine in Philadelphia. After a postdoctoral fellowship at the University of Washington, in 1990, Dr. Chen began his work at the Bristol-Myers Squib Company as a research scientist. In 1997, he became an immunology professor at the Mayo Clinic, Rochester, Minnesota, where he discovered the B7-H1 (PD-L1) molecule and the role of the B7-H1/PD-1 pathway in the evasion of tumor immunity. In 2004, he joined the faculty at the Johns Hopkins School of Medicine, where he helped initiate the first-in-man clinical trial using antibodies to block the B7-H1/PD-1 pathway for the treatment of human cancer. Dr. Lieping Chen currently serves as the United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Dermatology and Medical Oncology at Yale School of Medicine and co-Director of the Cancer Immunology Program of Yale Cancer Center in New Haven, CT. Dr. Chen has authored more than 300 scientific publications and has served on several committees and advisory boards for state, federal, and international research organizations and pharmaceutical companies. His honors include the William B. Coley Award (2014) and the AAI-Steinman Award (2016).